Want to see SG:V8Y full AI Analyst Report?
V8Y Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Operating And Free Cash FlowSustained positive operating and free cash flow across 2024–2025 and the TTM indicates the business can generate cash from core operations despite accounting losses. This durable cash conversion improves short-term liquidity, reduces immediate refinancing pressure, and supports funding of operations or targeted investments over the next several quarters.
Top-line Growth TrajectoryMeaningful revenue scaling since 2022 with sharp TTM increases signals growing product adoption and market traction. A sustainable top-line uptrend creates potential for operating leverage, better fixed-cost absorption, and a clearer path to margin expansion if management maintains execution and controls incremental costs as sales grow.
Gross ProfitabilityA mid-40% gross margin provides a structurally healthy unit economics baseline for a medical device firm. This margin buffer supports reinvestment in R&D and commercial expansion while leaving room to improve operating margins as revenue scales, making long-term profitability more attainable if SG&A growth is disciplined.
Bears Say
Negative Shareholders' EquityPersistent negative shareholders' equity is a structural balance-sheet weakness that reduces financial flexibility and raises refinancing and covenant risks. Over a multi-quarter horizon this limits ability to raise unsecured capital, can increase borrowing costs, and makes the company more vulnerable in downturns or if cash generation weakens.
Ongoing Operating LossesDespite revenue gains and healthy gross margins, continuing negative operating profit and net losses indicate costs still outpace sales. This structural shortfall stresses retained earnings and necessitates sustained cash generation or external funding to reach durable profitability, lengthening the timeline to break-even on a GAAP basis.
Historic Cash Flow VolatilityImproved recent cash flow is tempered by prior negative cash performance and a decline in free cash flow in the TTM versus 2025. This volatility signals execution risk and limited consistency in converting revenue to stable cash, complicating budgeting, capital allocation, and reducing predictability for creditors and investors over the medium term.
Quantum Healthcare Ltd. News
V8Y FAQ
What was Quantum Healthcare Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Quantum Healthcare Ltd.’s market cap?
Quantum Healthcare Ltd.’s market cap is S$25.18M.
When is Quantum Healthcare Ltd.’s upcoming earnings report date?
Quantum Healthcare Ltd.’s upcoming earnings report date is Aug 19, 2026 which is in 24 days.
How were Quantum Healthcare Ltd.’s earnings last quarter?
Quantum Healthcare Ltd. released its earnings results on May 12, 2026. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.
Is Quantum Healthcare Ltd. overvalued?
According to Wall Street analysts Quantum Healthcare Ltd.’s price is currently Undervalued.
Does Quantum Healthcare Ltd. pay dividends?
Quantum Healthcare Ltd. does not currently pay dividends.
What is Quantum Healthcare Ltd.’s EPS estimate?
Quantum Healthcare Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Healthcare Ltd. have?
Quantum Healthcare Ltd. has 12,587,903,000 shares outstanding.
What happened to Quantum Healthcare Ltd.’s price movement after its last earnings report?
Quantum Healthcare Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Quantum Healthcare Ltd.?
Currently, no hedge funds are holding shares in SG:V8Y
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quantum Healthcare Ltd.
Quantum Healthcare Limited, a Singapore-based enterprise established in 2005, specializes in the design, assembly, and commercialization of sophisticated therapeutic solutions for the minimally invasive management of intricate vascular diseases. The company conducts its operations across several divisions: its Vascular Business is dedicated to the development, production, and distribution of medical devices; the Healthcare Business segment provides comprehensive dental services; and a Corporate division handles general corporate functions. Beyond these core activities, Quantum Healthcare also offers management consultancy expertise to other healthcare organizations. The firm officially adopted its current moniker, Quantum Healthcare Limited, in July 2022, having previously traded as QT Vascular Ltd.
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
Aoxin Q&M Dental Group Ltd.
―
ISEC Healthcare Ltd
―
Asiamedic Limited
―